ARCHIVES

Decade-Long Cover-up?

This article is from The Cancer Letter archive.

Vol. 21 No. 01 | January 6, 1995

Download PDF Visit The Full Archive

Related Articles

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

Cancer Program Progress Detailed

March 5, 1976

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004

ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients

April 27, 2012

NCI Names 15 to Director’s Consumer Liaison Group.

January 14, 2005